[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"status-days":3,"stock-1795":32,"stock-themes-1795":127},[4,18],{"date":5,"taiex_close":6,"taiex_chg":7,"taiex_chg_pct":8,"advancers":9,"decliners":10,"unchanged":11,"stocks":12,"turnover_sum":13,"margin_balance":14,"margin_chg":15,"short_balance":16,"short_chg":17},"2026-10-12",49301.96,-11.480000000003201,-0.00023279657634922568,868,916,158,1971,1044705369816,9174215,2895,175930,1165,{"date":19,"taiex_close":20,"taiex_chg":21,"taiex_chg_pct":22,"advancers":23,"decliners":24,"unchanged":25,"stocks":26,"turnover_sum":27,"margin_balance":28,"margin_chg":29,"short_balance":30,"short_chg":31},"2026-10-13",48341.31,-960.6500000000015,-0.019485026558781926,444,1337,161,1975,1306098703553,9070158,-104057,168869,-7061,{"profile":33,"snapshot":50,"data_version":126},{"code":34,"name":35,"full_name":36,"market":37,"kind":38,"industry":39,"listed_date":40,"chairman":41,"president":42,"capital":43,"shares":44,"founded_date":45,"website":46,"address":47,"english_name":48,"dividend_frequency":49},"1795","美時","美時化學製藥股份有限公司","sii","stock","生技醫療業","2019-12-16","Vilhelm Robert Wessman","Petar Antonov Vazharov",2701547570,270154757,"1966-06-30","http:\u002F\u002Fwww.lotuspharm.com.tw","臺北市信義區松仁路277號17樓","Lotus Pharm","每年",{"code":34,"name":35,"market":37,"kind":38,"industry":39,"close":51,"chg":52,"chg_pct":53,"ret_5d":54,"ret_20d":55,"volume":56,"turnover":57,"mcap":58,"signals":59,"as_of":19,"ref_price":65,"ret_60d":66,"ret_ytd":67,"open":68,"high":69,"low":51,"pe":70,"pb":71,"dy":72,"foreign_net_1d":73,"foreign_net_5d":74,"trust_net_1d":75,"trust_net_5d":76,"dealer_net_1d":77,"dealer_net_5d":78,"foreign_holding_pct":79,"margin_balance":80,"margin_chg":81,"short_balance":82,"short_chg":83,"large_holder_pct":84,"large_holder_chg_1w":85,"large_holder_chg_4w":86,"holders_date":87,"high_52w":88,"low_52w":89,"rev_period":90,"rev_yoy":91,"eps_period":92,"eps":93,"spark":94},178,-5.5,-0.02997275204359673,0.0028169014084507005,0.005649717514124131,1590057,287439427,48111673400,[60,61,62,63,64],"rev_yoy","rev_yoy_3m","foreign_buy_5d","trust_buy_5d","holders_up",183.5,-0.07710079518590152,-0.3542966694233516,184,186,12.58,1.95,1.52,51665,139552,0,428,-17516,46524,49.93,8384,-5,1,-1,53.15,0.04999999999999716,0.6499999999999986,"2026-10-09",369.5,170.5,"2026-09",127.96,"2026-Q2",2.3761563030563804,[95,96,97,98,99,100,68,101,102,103,104,105,69,106,99,95,107,96,99,95,108,65,68,109,110,111,112,113,114,113,115,69,109,68,116,117,108,108,118,119,120,120,121,51,122,122,51,101,123,102,123,118,119,124,123,124,125,108,65,51],188,189,190.5,192.5,188.5,185,176.5,175.5,173,175,187,190,193.5,180.5,186.5,195,196.5,196,194,195.5,193,181.5,182,179,177,173.5,178.5,180,177.5,176,182.5,"20261013-fcba10",[128],{"theme":129,"segment":137,"tier":138,"role":139,"relevance":140,"note":141,"peers":142,"upstream":201,"downstream":202},{"id":130,"slug":131,"name":132,"category":133,"ret_1d":136},56,"cdmo-generics","CDMO 與學名藥",{"slug":134,"name":135},"biotech","生技醫療",-0.010249642314885767,"學名藥與特殊學名藥","midstream","leader","high","學名藥與抗癌藥",[143,156,169,180,191],{"code":144,"name":145,"role":146,"relevance":147,"note":148,"industry":39,"close":149,"chg_pct":150,"ret_5d":151,"ret_20d":152,"mcap":153,"turnover":154,"signals":155},"4123","晟德","niche","mid","藥品與生技投資",30.9,-0.01748807631160576,0.0016207455429497752,0.01812191103789118,24906055080,45611069,[60,61,62],{"code":157,"name":158,"role":146,"relevance":140,"note":159,"industry":39,"close":160,"chg_pct":161,"ret_5d":162,"ret_20d":163,"mcap":164,"turnover":165,"signals":166},"4105","東洋","癌症用藥與特殊學名藥",82.1,0.003667481662591676,0.04853128991060007,0.06072351421188604,20414165000,87267240,[60,61,167,62,168,64],"eps_yoy","foreign_streak_3d",{"code":170,"name":171,"role":146,"relevance":140,"note":172,"industry":39,"close":173,"chg_pct":174,"ret_5d":175,"ret_20d":176,"mcap":177,"turnover":178,"signals":179},"3705","永信","學名藥",60.7,0.00830564784053145,0.07243816254416946,0.08392857142857135,16171875068.1,42305180,[60,61,167,62,168],{"code":181,"name":182,"role":146,"relevance":140,"note":183,"industry":39,"close":184,"chg_pct":185,"ret_5d":186,"ret_20d":187,"mcap":188,"turnover":189,"signals":190},"1720","生達","學名藥與保健品",57.2,-0.005217391304347729,0.02508960573476715,0.01598579040852588,11243557925.6,19191122,[60,61,167],{"code":192,"name":193,"role":146,"relevance":147,"note":183,"industry":39,"close":194,"chg_pct":195,"ret_5d":196,"ret_20d":197,"mcap":198,"turnover":199,"signals":200},"3716","中化控股",34,-0.004392386530014503,0.008902077151335286,0.0014727540500736325,5119693174,8285952,[167],[],[203],{"id":204,"slug":205,"name":206,"category":207,"ret_1d":208},55,"new-drugs","新藥研發",{"slug":134,"name":135},-0.025792561311777984]